Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

Share Price is delayed by 15 minutes
Get Live Data
64.00    2.00 (3.23%)
Bid:
63.00
Ask:
65.00
Spread: 2.00 (3.175%)
Market Cap: £15.59m
MYX Live PriceLast checked at - London Stock Exchange

Intraday Mycelx Di Share Chart

Trading Update & $3.9m Project Award

3 Nov 2025 07:00

RNS Number : 7945F
MyCelx Technologies Corporation
03 November 2025
 

The information contained within this Announcement is deemed by MYCELX Technologies Corporation to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").

 

3 November 2025

 

MYCELX Technologies Corporation

("MYCELX" or the "Company")

 

Trading Update

 

MYCELX Awarded $3.9m Produced Water Project in the US Permian Basin

 

MYCELX Technologies Corporation (AIM: MYX), the clean water and clean air technology company, is pleased to announce it has been awarded a $3.9 million produced water treatment project in the US Permian Basin, the most active and productive oil region in the world. The system will be owned and operated by a major Midstream Operating Company that provides water management services to major producers in the region. The company continues to be in advanced discussions on a number of additional US Permian Basin projects.

 

Under the contract, MYCELX will supply its patented REGEN system, an advanced water treatment technology with a proven track record of outperforming the competition. The system will be installed at one of the operator's key water handling facilities to manage their customers' significantly increased water volumes resulting from rising water-to-oil ratios during production and induced seismicity caused by pressurized disposal well usage. This project, which is expected to be delivered in 2026 but is included within current market expectations, marks MYCELX's expanding presence in the US Permian Basin and underscores growing industry confidence in the Company's innovative and proven water treatment solutions.

 

MYCELX Presents at Middle East Symposium on Successful REGEN Retrofit in Oman

 

The Company was pleased to address the recent Middle East Produced Water Oilfield Symposium and Exhibition in Qatar, presenting the case study on MYCELX's installation of its first REGEN Retrofit Package at the Enhanced Oil Recovery ('EOR') field operated by Petroleum Development Oman ('PDO'). Underperforming nutshell filter vessels can now be modified to transition to MYCELX's REGEN filter media, enabling increased production and delivering significantly improved water quality and performance reliability. The Company is set to deliver its second project with PDO later this year.

 

These projects and the recent technical presentation highlight MYCELX's continued global momentum and the growing recognition of its innovative, proven solutions for the most demanding produced water treatment challenges.

 

Connie Mixon, CEO, commented:

 

"We are delighted to have been selected by a leading Midstream Operator in the US Permian Basin for this significant project, which further validates the strength and differentiation of our REGEN technology. This award represents an important milestone in expanding our presence in the most active energy region in the world and demonstrates the industry's increasing confidence in MYCELX's proven ability to solve complex produced water challenges.

 

The recent recognition at the Produced Water Oilfield Symposium in Qatar and our continued collaboration with Petroleum Development Oman further underscore the growing global demand for advanced water treatment solutions that deliver measurable performance and reliability. With a strong pipeline of opportunities ahead, MYCELX is well positioned to build on this momentum and continue driving sustainable growth in both domestic and international markets."

 

 

For further information, please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

Giles Balleny / Callum Davidson / Elysia Bough (Corporate Finance)

Harriet Ward (Corporate Broking)

Jasper Berry / Michael Johnson (Sales)

 

 

 

Tel: +44 20 7220 0500

 

Celicourt Communications (Financial PR)

Mark Antelme

Charlie Denley-Myerson

 

Tel: +44 20 7770 6424

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDLLFBEFLLFBB
Date   Source Headline
3rd Jun 20267:00 amRNSAppointment of Non-Executive Director
12th May 20267:00 amRNSNew Gulf of Mexico Lease Award with Super Major
7th May 20267:00 amRNSFinal Results for the Year Ending 31 December 2025
16th Feb 202610:46 amRNSDirector Dealing
20th Jan 20267:00 amRNSTrading Update
22nd Dec 202511:27 amRNSHolding(s) in Company
7th Nov 20252:51 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTrading Update & $3.9m Project Award
1st Oct 20257:00 amRNSHolding(s) in Company
23rd Sep 20255:00 pmRNSResult of Annual Meeting
23rd Sep 20257:00 amRNSAppointment of New Chairman and Succession
17th Sep 20257:00 amRNSHalf Year Results Statement
11th Sep 20257:00 amRNSClosure of Restricted Stock Line
22nd Aug 20257:00 amRNSMailing of Notice of 2025 Annual Meeting
20th Aug 20257:00 amRNSOpening of $500,000 Line of Credit
17th Jul 20257:00 amRNSTrading Update
10th Jun 20257:00 amRNSMailing of 2024 Annual Report
21st May 20253:25 pmRNSDirector Dealing
19th May 202511:33 amRNSHolding(s) in Company
15th May 202511:21 amRNSHolding(s) in Company
12th May 20257:00 amRNSFinal Results for the Year Ending 31 December 2024
6th May 20257:00 amRNSPFAS Contract Award
1st May 20257:00 amRNS-REPA Announces Actions to Combat PFAS Contamination
10th Apr 20257:00 amRNSGrant of Share Options
7th Apr 20257:00 amRNSOperational and Trading Update
30th Jan 20257:00 amRNSChange of Adviser
6th Jan 20257:00 amRNSYear-end Update
29th Oct 20247:00 amRNSProject Award
24th Sep 20247:00 amRNSHalf Year Results Statement
23rd Sep 20247:00 amRNSTrading Update
6th Sep 202411:54 amRNSHolding(s) in Company
5th Sep 20245:17 pmRNSHolding(s) in Company
30th Aug 20247:00 amRNSBroker Option
23rd Aug 202411:05 amRNSDirector Dealings & Total Voting Rights
23rd Aug 20247:00 amRNSProposed Placing and Subscription
19th Jul 202410:36 amRNSPFAS Update
9th Jul 20242:23 pmRNSResult of AGM
9th Jul 20241:39 pmRNSHolding(s) in Company
4th Jun 20247:00 amRNS2023 Annual Report & Notice of 2024 Annual Meeting
21st May 20247:00 amRNSDirector Dealing
16th May 20247:00 amRNSFinal Results for the Year Ending 31 December 2023
24th Apr 20247:00 amRNSBusiness Update
11th Apr 20247:00 amRNSEPA Publishes National Drinking Water Standards
26th Mar 20243:30 pmRNSDirector Dealing
26th Mar 20247:00 amRNSDirector Dealing
22nd Mar 20247:00 amRNSDirector Dealing
21st Mar 20247:00 amRNSDirector Dealing
18th Mar 20247:00 amRNSGrant of Share Options to Chief Financial Officer
4th Mar 20247:00 amRNSSaudi Arabia Business Operation Sale Completion
22nd Feb 20247:02 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.